Although previous studies have demonstrated that G to A mutation at amino acid codon 655 of the human erbB-2/HER2 gene is a new allele polymorphism of the ERBB2 gene [26,27], the exact role of such mutation as a therapeutic target in luminal-like breast cancer remains further clinical elucidation. Here, ERBB2 is linked to breast carcinoma.